COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices
Open Access
- 14 December 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 144, 163-172
- https://doi.org/10.1016/j.jclinepi.2021.12.015
Abstract
No abstract availableFunding Information
- National Key Research and Development Program of China (2018YFC1705500)
- National Office for Philosophy and Social Sciences (19ZDA142)
This publication has 21 references indexed in Scilit:
- Telemedicine for neuromuscular disorders during the COVID-19 outbreakZeitschrift für Neurologie, 2020
- Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid reviewBMJ, 2020
- A quality evaluation of guidelines on five different viruses causing public health emergencies of international concernAnnals of Translational Medicine, 2020
- A Reporting Tool for Practice Guidelines in Health Care: The RIGHT StatementAnnals of Internal Medicine, 2016
- Why we can't trust clinical guidelinesBMJ, 2013
- In Guidelines We Cannot TrustJAMA Internal Medicine, 2012
- GRADE guidelines: 9. Rating up the quality of evidenceJournal of Clinical Epidemiology, 2011
- Clinical Practice Guidelines We Can TrustPublished by The National Academies Press ,2011
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- AGREE II: advancing guideline development, reporting and evaluation in health careCMAJ : Canadian Medical Association Journal, 2010